• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Jordan J. Cochuyt, BS

Latest:

Impact of Travel Distance on Quality Outcomes in Colorectal Cancer

This study identified characteristics of patients with colorectal cancer who traveled farther for surgery and found that those who traveled tended to stay longer at the hospital.


Chelsea A. Pizzo, MPH

Latest:

Hospital Performance in a Statewide Commercial Insurer Episode-Based Incentive Program

Some hospitals were able to outperform others in a commercial insurer episode-based incentive program, but there was little evidence of global reductions in episode spending.


Sushmita Gordhandas, MD

Latest:

Providing Patients With Cancer Access to Affordable Housing During Treatment

Patients traveling for cancer treatment often incur financial burdens. The members of the Alliance of Dedicated Cancer Centers should play a role in mitigating housing-associated costs for patients during cancer treatment.


Jessica Arguelles, BS

Latest:

Cost-effectiveness of a 3-Year Tele-Messaging Intervention for Positive Airway Pressure Use

Long-term tele-messaging was more effective than no messaging and short-term messaging for positive airway pressure use, and it was highly likely to be cost-effective with an acceptable willingness-to-pay threshold.


Christine Ahn, MBA

Latest:

Modeling Financial Outcomes and Quantifying Risk in Episode-Based Payment Models

This article provides a description of prospective financial simulation methodology and use cases with empirical data for episode-based bundled payments, including implications for contract negotiations and value-based care redesign.


Kimberly Lenz, PharmD, MBA

Latest:

Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid Population

The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan.


Joanna Bugbee, BBA

Latest:

Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans

This study provides insight on the experiences of patients of a national health plan with 2 structural determinants of health—health care discrimination and health literacy—and how those interact with social determinants of health and patient demographics.


John W. Epling, MD, MSEd

Latest:

A “Sludge Audit” for Health System Colorectal Cancer Screening Services

A systematic, mixed methods “sludge audit” identified novel health system delivery targets for improving colorectal cancer screening services.


Jeffrey Dong, MD

Latest:

Turnover Among New Medicare Advantage Enrollees May Be Greater Than Perceived

Enrollees who join Medicare Advantage undergo significant turnover in the years following enrollment.


Peter Buerhaus, PhD, RN

Latest:

Dual-Eligible Beneficiaries and Inadequate Access to Primary Care Providers

States with the most restrictive scope-of-practice laws have an inadequate supply of primary care clinicians to serve a high concentration of dual-eligible beneficiaries.


Cynthia Sacco, MD

Latest:

Experience Incentivizing Reduction of Racial and Ethnic Disparities in a Medicaid Hospital Quality Incentive Program

Construction of a composite measure, use of a summary disparity statistic, and measure selection are key considerations in the design of equity-focused payment programs.



Christopher S. Saigal, MD, MPH

Latest:

Modeling Financial Outcomes and Quantifying Risk in Episode-Based Payment Models

This article provides a description of prospective financial simulation methodology and use cases with empirical data for episode-based bundled payments, including implications for contract negotiations and value-based care redesign.


Chelsea Richwine, PhD, MA

Latest:

Trends in Electronic Health Record Capabilities for Tracking Documentation Time

This study examines trends in hospitals’ access to and use of data from electronic health record (EHR) developers that quantify clinicians’ time spent documenting clinical care in EHRs.


Jessica K. DeMartino, PhD

Latest:

Insurer Costs of COVID-19 by Disease Severity and Duration

Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.


Louie Lu, PhD

Latest:

Digital Musculoskeletal Program Is Associated With Decreased Joint Replacement Rates

Adults with osteoarthritis who took part in a digital musculoskeletal program had lower rates of knee and hip arthroplasty at 12 months vs those using traditional care.


Kathryn Gray, MA

Latest:

Predicting Hospitalizations for Patients With Chronic Kidney Disease

The authors developed an algorithm that uses medical claims to identify patients with chronic kidney disease who are at greatest risk of being hospitalized within 90 days.


Autumn D. Zuckerman, PharmD

Latest:

Rheumatoid Arthritis Medication Adherence in a Health System Specialty Pharmacy

Integrated health system specialty pharmacies provide specialized services to patients, resulting in high rates of adherence to and financial assistance with specialty disease-modifying antirheumatic drugs.


Steven Dean, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Yajun Emily Zhu, MS

Latest:

Treatment Patterns for Patients With Advanced/Metastatic Cancers by Site of Care

Treatment patterns and overall survival were similar regardless of site of care between patients receiving anticancer therapy in the hospital outpatient vs physician office setting.


Ann M. Holmes, PhD

Latest:

The Relationship Between Preventive Dental Care and Overall Medical Expenditures

Using an instrumental variable approach, this study is the first to present causal estimates of the effect of preventive dental visits on overall medical expenditures.


Paul K. Halverson, DrPH

Latest:

Primary Care Case Conferences to Mitigate Social Determinants of Health: A Case Study From One FQHC System

This article describes perceived benefits, facilitators, and challenges of conducting interprofessional team case conferences in primary care settings to address patients’ complex social needs.


Jeremy Gleeson, MD

Latest:

Cold Agglutinin Disease: Clinical Pearls

Take-aways from a discussion on the management of cold agglutinin disease, with expert insight on navigating the healthcare system to optimize patient care.


David J. Cook, MD, MHA

Latest:

A Data-Based Foundation for Managing Hypertension Services

Analysis of more than 16 million visits for hypertension care suggests that a large fraction of face-to-face care is low value and could be provided differently or potentially eliminated.


Connie Lu, MPH

Latest:

Intersection of Complexity and High Utilization Among Health Center Patients Aged 18 to 64 Years

This paper utilizes latent class analysis to identify subgroups of complex conditions and of super-utilizers among health center patients to inform clinically tailored efforts.


Gabriela Gracia, PhD

Latest:

Association of 340B Contract Pharmacy Growth With County-Level Characteristics

The growth of 340B contract pharmacies since 2010 is unprecedented. This study’s findings suggest that patterns of growth differ between safety-net clinics and hospitals.


Lauren Biscaldi

Latest:

Merck Files Lawsuit to Halt Medicare Drug Price Negotiations

According to a spokesperson, Merck is prepared to take the lawsuit to the Supreme Court as it challenges drug price negotiations as part of the Inflation Reduction Act.



John F.P. Bridges, PhD

Latest:

Integrating Primary Care and Public Health for Advance Care Planning

This article proposes a new model, Public-Primary ACP, that leverages coordination between primary care and public health workforces to improve delivery of advance care planning.


Arnold Milstein, MD

Latest:

Safety vs Price in the Generic Drug Market: Metformin

The generic drug market focuses on price. However, multiple generic metformin drugs have been recalled due to poor drug quality. The authors examine price and quality after these recalls.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.